Table 2.
CMR indices at baseline and follow-up
| Normal range | Baseline | Follow-up | P value | |
|---|---|---|---|---|
| Body surface area | — | 1.9 ± 0.2 | 1.9 ± 0.3 | .313 |
| LVEDV, mL | 77–195 | 129.7 ± 37.7 | 130.9 ± 32.6 | .765 |
| LVEDVi, mL/m2 | 47–92 | 66.9 ± 15.4 | 66.8 ± 9.6 | .962 |
| LVESV, mL | 19–72 | 44.6 ± 16.9 | 46.9 ± 15.8 | .356 |
| LVESVi, mL/m2 | 13–30 | 22.9 ± 7.2 | 24.4 ± 5.1 | .305 |
| LVEF, % | 56–78 | 66.1 ± 6.4 | 64.6 ± 6.7 | .375 |
| RVEDV, mL | 88–227 | 147.4 ± 46.0 | 155.1 ± 40.3 | .126 |
| RVEDVi, mL/m2 | 47–92 | 75.9 ± 18.4 | 78.8 ± 11.4 | .294 |
| RVESV, mL | 23–103 | 63.1 ± 26.6 | 71.2 ± 21.7 | .041∗ |
| RVESVi, mL/m2 | 15–45 | 32.1 ± 11.6 | 36.2 ± 7.4 | .050∗ |
| RVEF, % | 47–74 | 58.1 ± 7.0 | 54.6 ± 5.2 | .071 |
| RVOT-EDV, mL | NA | 10.3 ± 4.8 | 11.3 ± 3.7 | .189 |
| RVOT-EDVi, mL/m2 | NA | 5.0 ± 2.5 | 5.8 ± 1.6 | .215 |
| RVOT as proportion of RVEDV, % | NA | 6.8 ± 2.1 | 7.4 ± 1.8 | .214 |
Values are mean ± SD, unless otherwise indicated.
CMR = cardiac magnetic resonance; EDV = end-diastolic volume; EDVi = end-diastolic volume indexed to body surface area; LVEDV = left ventricular end-diastolic volume; LVEDVi = left ventricular end-diastolic volume indexed to body surface area; LVEF = left ventricular ejection fraction; LVESV = left ventricular end-systolic volume; LVESVi = left ventricular end-systolic volume indexed to body surface area; NA = not applicable; RVEDV = right ventricular end-diastolic volume; RVEDVi = right ventricular end-diastolic volume indexed to body surface area; RVEF = right ventricular ejection fraction; RVESV = right ventricular end-systolic volume; RVESVi = right ventricular end-systolic volume indexed to body surface area; RVOT = right ventricular outflow tract.
P-value ≤ .05.